AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline Transcript
Think we can start. Hi, and welcome, everyone. Today's breakout session (inaudible), called New CVRM: Emerging Pipeline. I'm Thomas Larsen from AstraZeneca the Investor Relations team, and I will be the moderator to for this breakout session.
With me today, I have members from our bio-pharmaceutical team. We have Regina Fritsche Danielson, Senior VP for the early stage R&D. We have Tomas Andersson, VP late-stage R&D, and we have Lori Kreamer, VP, CRM biopharmaceuticals business unit.
This breakout session will last around 30 minutes, there will be a short presentation, followed by Q&A. As usual, the presentations are available on astrazeneca.com/investors, and we also sent the presentations to people on our distribution list.
Before I hand over to today's presenter, I would like to remind you that this meeting is being recorded, and that this event is for [south] side analysts and institutional investors only.
To ask a question in the webinar, please raise your hand using the icon on the menu bar. We will then open up your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
